The Fact About Investigational New Drug (IND) Application That No One Is Suggesting
It makes it possible for thirty days for FDA assessment to ensure the trials will likely not expose subjects to unreasonable pitfalls. The FDA critiques INDs from clinical, chemistry, pharmacology and statistical perspectives and might notify the sponsor of deficiencies. Clinical trials can then continue Except if a clinical hold is issued.- An IND